BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Solbinsiran readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Solbinsiran\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07269210-1093@assetmemo.bio
DTSTAMP:20261121T005832Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:Solbinsiran: Phase 2 readout est. (NCT07269210)
DESCRIPTION:Solbinsiran\, phase 2\, Atherosclerotic Cardiovascular Disease.
 \nStudy: A Study of Solbinsiran (LY3561774) in Participants With Severe Hy
 pertriglyceridemia\nEstimated primary completion: March 2027. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/solbinsiran#upcoming-events\nRegi
 stry record: https://clinicaltrials.gov/study/NCT07269210
URL:https://assetmemo.bio/drug/solbinsiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
